Abbott Laboratories Stock (ISIN: US0028241000) Holds Steady Amid Moderate Buy Consensus and FY2026 G

NodeGuardian · 2026-03-16T09:02:37+00:00

Abbott Laboratories' stock is at $108, with a "Moderate Buy" consensus and a $136 target. Despite recent revenue misses, strong EPS guidance and appeal to European investors highlight its stability and market presence.

NodeGuardian

2026-03-16 09:02:37

Abstract generation in progress

Abbott Laboratories’ stock is trading around $108 with institutional support, maintaining a “Moderate Buy” consensus and a $136 target despite recent Q4 revenue misses. The company’s FY2026 EPS guidance of $5.55-$5.80 reflects resilience in its diagnostics and medical devices segments. European investors are drawn to Abbott’s stability, strong dividend, and significant presence in DACH markets.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.